Senseonics seeks iCGM designation for implantable glucose monitor
Dive Brief: Senseonics filed a submission with the Food and Drug Administration that will allow it to integrate its implantable glucose monitor with insulin pens
Dive Brief: Senseonics filed a submission with the Food and Drug Administration that will allow it to integrate its implantable glucose monitor with insulin pens
Ryan Self, VP Advisory Services at Strata Decision Technology Healthcare organizations have access to a wealth of data, yet 92% of healthcare professionals say organizations should
The US Food and Drug Administration (FDA) has announced the approval of Sanofi and Regeneron’s interleukin (IL)-4 and IL-13 monoclonal antibody, Dupixent, for the US